查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790458

臨床檢測設備和輔助解決方案市場規模、佔有率和趨勢分析報告：按類型、階段、地區和細分市場預測，2025 年至 2033 年

Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Type (Sourcing, Supply/Logistics, Service), By Phase (Phase I, II, III, IV), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

臨床檢測設備和輔助解決方案市場概覽

預計全球臨床檢測設備和輔助解決方案市場在 2024 年的價值將達到 32.1 億美元，到 2033 年將達到 68.8 億美元，2025 年至 2033 年的複合年成長率為 8.92%。市場成長的動力來自於臨床檢測日益複雜和全球化，這需要高度專業化、特定於通訊協定的設備和物流支援。

分散式和混合式臨床檢測模式的迅速普及使得遠端監控設備、穿戴式感測器和家用診斷試劑套件成為必需，從而大大擴展了輔助服務的範圍。臨床檢測模式的轉變，尤其是分散式檢查和混合式檢測的興起，大大增加了對專用設備和支援服務的需求，以促進遠端、無場地和居家研究環境。嚴重依賴集中式臨床實驗地點的傳統模式正在被一種更加以患者為中心的方法所取代，這種模式需要遠端監控設備、行動醫療套件、穿戴式設備以及用於生物樣本的宅配物流。例如，美國FDA 正在透過其 2023 年指南草案推廣分散式臨床檢測 (DCT)，敦促申辦者採用數位健康技術和遠端照護工具，以改善患者的可近性和數據品質。這些發展正在推動 CRO 和申辦者採購可靠的溫敏包裝、檢驗的家用醫療設備以及即時追蹤系統，以監督跨地區的設備運輸。這種轉變正在將臨床測試設備供應商的角色從被動供應商轉變為主動的綜合服務合作夥伴，負責確保遵守法規、正確校準以及符合測試協議的交貨時間表。

此外，政府和非營利資助機構擴大支持早期研究、轉化醫學和研究者主導的臨床實驗，所有這些都依賴於及時獲得臨床實驗用品。美國國立衛生研究院的「我們所有人」研究計畫和歐盟的「地平線歐洲」框架等舉措正在突破患者群體多樣性和精準診斷的界限，需要製定適應性強且靈活的設備供應策略。例如，「地平線歐洲」已撥款約 1,114.9 億美元（950 億歐元）用於 2027 年之前的科學和創新，其中多個計劃專注於個人化醫療、穿戴式監測和遠端醫療綜合臨床測試。這些舉措正在創造對現場就緒套件、雲端連接監測設備以及臨床實驗追蹤的試劑和生技藥品運輸的需求。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章臨床檢測設備和輔助解決方案市場：變數、趨勢和範圍

  • 市場體系展望
  • 臨床檢測設備和輔助解決方案市場動態
  • 科技
  • 定價模式分析
  • 臨床測試設備和輔助解決方案市場：分析工具

第4章：臨床檢測設備和輔助解決方案市場：按類型估計和趨勢分析

  • 細分儀表板
  • 全球臨床檢測設備和輔助解決方案市場類型變化分析
  • 全球臨床檢測設備及輔助解決方案市場規模及趨勢分析（2021-2033）
  • 採購
    • 採購
    • 租賃
  • 供應/物流
    • 運輸
    • 包裝
    • 其他
  • 服務
    • 校準
    • 設備維護
    • 其他
  • 其他

第5章：臨床檢測設備和輔助解決方案市場：階段、估計和趨勢分析

  • 細分儀表板
  • 全球臨床檢測設備和輔助解決方案市場的階段波動分析
  • 全球臨床檢測設備和支援解決方案市場規模和趨勢分析（分階段，2021-2033）
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第6章：臨床檢測設備和輔助解決方案市場：類型、階段、區域、估計和趨勢分析

  • 區域市場儀表板
  • 全球區域市場概況
  • 2021-2033 年市場規模、預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 公司分類
    • 市場領導者
    • 新參與企業
  • 2024 年公司市場佔有率/估值分析
  • 公司簡介
    • Ancillare, LP
    • Imperial CRS, Inc.
    • Woodley Equipment Company Ltd.
    • Thermo Fisher Scientific, Inc.
    • Parexel International（MA）Corporation
    • Emsere
    • Quipment SAS
    • IRM
    • Marken
    • Myonex
    • Yourway
Product Code: GVR-4-68039-533-5

Clinical Trial Equipment & Ancillary Solutions Market Summary

The global clinical trial equipment & ancillary solutions market size was valued at USD 3.21 billion in 2024 and is projected to reach USD 6.88 billion by 2033, growing at a CAGR of 8.92% from 2025 to 2033. The growth of the market is due to the increasing complexity and globalization of clinical trials, which demand highly specialized, protocol-specific equipment and logistics support.

The rapid adoption of decentralized and hybrid trial models requires remote monitoring devices, wearable sensors, and home-use diagnostic kits, significantly expanding the scope of ancillary services. The transformation of clinical trial models, especially the increase of decentralized and hybrid trials, has significantly raised the demand for specialized equipment and support services that facilitate remote, site-less, and home-based research settings. The traditional model, which relied heavily on centralized trial sites, is being replaced by more patient-focused approaches, requiring remote monitoring devices, mobile health kits, wearables, and courier-enabled logistics for biological samples. For example, the U.S. FDA has promoted decentralized clinical trials (DCTs) through its 2023 draft guidance, urging sponsors to adopt digital health technologies and remote care tools to enhance patient access and data quality. These developments are leading CROs and sponsors to acquire reliable, temperature-sensitive packaging, validated medical devices for home use, and real-time tracking systems to oversee equipment shipments across different regions. This shift has transformed the role of clinical trial equipment suppliers from passive vendors into active, integrated service partners responsible for ensuring regulatory compliance, proper calibration, and delivery schedules aligned with study protocols.

Additionally, government and non-profit funding organizations are increasingly supporting early-stage research, translational medicine, and investigator-initiated trials, all of which depend on timely access to ancillary trial supplies. Initiatives like the NIH's All of Us Research Program and the European Union's Horizon Europe framework are expanding the boundaries of patient cohort diversity and precision diagnostics, which require adaptive and flexible equipment supply strategies. For example, Horizon Europe allocates nearly USD 111.49 billion (€95 billion) toward science and innovation through 2027, with multiple projects focused on personalized medicine, wearable monitoring, and telehealth-integrated clinical trials. These initiatives generate demand for site-ready kits, cloud-connected monitoring devices, and digitally traceable shipping for reagents and biologics.

Global Clinical Trials Equipment & Ancillary Solutions Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global clinical trial equipment & ancillary solutions market report based on type, phase and region.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Sourcing
    • Procurement
    • Equipment
    • Ancillaries
    • Rental
    • Equipment
    • Ancillaries
  • Supply/Logistics
    • Transportation
    • Packaging
    • Others
  • Service
    • Calibrations
    • Equipment servicing
    • Others
  • Others
  • Phase Outlook (Revenue, USD Million, 2021 - 2033)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Clinical Trial Equipment & Ancillary Solutions Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Clinical Trial Equipment & Ancillary Solutions Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Clinical Trial Equipment & Ancillary Solutions Market: Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis

Chapter 4. Clinical Trial Equipment & Ancillary Solutions Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Clinical Trial Equipment & Ancillary Solutions Market Type Movement Analysis
  • 4.3. Global Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Sourcing
    • 4.4.1. Sourcing Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.4.2. Procurement
      • 4.4.2.1. Procurement Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.2. Equipment
        • 4.4.2.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.3. Ancillaries
        • 4.4.2.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Rental
      • 4.4.3.1. Rental Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Equipment
        • 4.4.3.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Ancillaries
        • 4.4.3.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Supply/Logistics
    • 4.5.1. Supply/Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Transportation
      • 4.5.2.1. Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Packaging
      • 4.5.3.1. Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Service
    • 4.6.1. Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Calibrations
      • 4.6.2.1. Calibrations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Equipment servicing
      • 4.6.3.1. Equipment Servicing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Clinical Trial Equipment & Ancillary Solutions Market: Phase Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Clinical Trial Equipment & Ancillary Solutions Market Phase Movement Analysis
  • 5.3. Global Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Phase, 2021 to 2033 (USD Million)
  • 5.4. Phase I
    • 5.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Phase II
    • 5.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Phase III
    • 5.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Phase IV
    • 5.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Clinical Trial Equipment & Ancillary Solutions Market: Regional Estimates & Trend Analysis by Type, Phase

  • 6.1. Regional Market Dashboard
  • 6.2. Global Regional Market Snapshot
  • 6.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
    • 7.1.1. Market Leaders
    • 7.1.2. Emerging Players
  • 7.2. Company Market Share/Assessment Analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. Ancillare, LP
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Service benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Imperial CRS, Inc.
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Service benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Woodley Equipment Company Ltd.
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Service benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Thermo Fisher Scientific, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Service benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Parexel International (MA) Corporation
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Service benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Emsere
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Service benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Quipment SAS
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Service benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. IRM
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Service benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Marken
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Service benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Myonex
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Service benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Yourway
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Service benchmarking
      • 7.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 5 U.S. clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 6 U.S. clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 7 Canada clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 8 Canada clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 9 Europe clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 10 Europe clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 11 Europe clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 12 Germany clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 13 Germany clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 14 UK clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 15 UK clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 16 France clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 17 France clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 18 Italy clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 19 Italy clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 20 Spain clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 21 Spain clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 22 Denmark clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 23 Denmark clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 24 Sweden clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 25 Sweden clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 26 Norway clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 27 Norway clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 28 Asia Pacific clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 31 China clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 32 China clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 33 Japan clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 34 Japan clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 35 India clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 36 India clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 37 South Korea clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 38 South Korea clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 39 Australia clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 40 Australia clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 41 Thailand clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 42 Thailand clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 43 Latin America clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 44 Latin America clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 45 Latin America clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 46 Brazil clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 47 Brazil clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 48 Mexico clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 49 Mexico clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 50 Argentina clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 51 Argentina clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 52 Colombia clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 53 Colombia clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 54 MEA clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 55 MEA clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 56 MEA clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 57 South Africa clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 58 South Africa clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 59 Saudi Arabia clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 60 Saudi Arabia clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 61 UAE clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 62 UAE clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 63 Kuwait clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 64 Kuwait clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Clinical trial equipment & ancillary solutions market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2024 (USD Million)
  • Fig. 17 Ancillary market outlook, 2024 (USD Million)
  • Fig. 18 Clinical trial equipment & ancillary solutions market dynamics
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 Clinical trial equipment & ancillary solutions market type outlook: Segment dashboard
  • Fig. 22 Clinical trial equipment & ancillary solutions market, by type segment: Market share, 2025 & 2033
  • Fig. 23 Sourcing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Procurement market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Ancillaries market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Rental market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Ancillaries market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Supply/Logistics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Transportation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Packaging market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Service market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Calibrations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Equipment servicing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Clinical trial equipment & ancillary solutions market phase outlook: Segment dashboard
  • Fig. 39 Clinical trial equipment & ancillary solutions market, by phase segment: Market share, 2024 & 2033
  • Fig. 40 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Phase IV market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Regional market: Key takeaways
  • Fig. 45 Regional marketplace: Key takeaways
  • Fig. 46 North America clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 US clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Europe clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 UK clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Germany clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 France clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Italy clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Denmark clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Norway clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Sweden clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Asia Pacific clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Japan clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 China clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 India clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Australia clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Korea clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Thailand clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Latin America clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Brazil clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 MEA clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 South Africa clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Saudi Arabia clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Kuwait clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 UAE clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Market participant categorization
  • Fig. 98 Heat map analysis